Skip to main content
. 2020 Oct 13;10:17054. doi: 10.1038/s41598-020-73930-3

Table 4.

Multivariable analysis for baseline prognostic factors for progression-free survival and overall survival.

graphic file with name 41598_2020_73930_Tab4_HTML.jpg

AFP α-fetoprotein, ALBI albumin-bilirubin, BCLC Barcelona Clinic Liver Cancer, CI confidence interval, FGFR4 fibroblast growth factor receptor 4, HR hazard ratio, NOS3 nitric oxide synthase 3, PVI portal vein invasion, RDI relative dose intensity.